| Equity and other equity items |
2 6 . Equity and other equity items Toyota will invest efficiently in the maintenance and replacement of conventional manufacturing facilities and the introduction of new products, while focusing its capital investments and research and development on areas that contribute to strengthening competitiveness and future growth. Through these activities, Toyota aims to improve corporate value and maintain sustainable growth to realize a new mobility society. These activities are generally financed by Toyota Motor Corporation’s shareholders’ equity, supplemented by short-term and long-term debt as necessary. The amounts of Toyota Motor Corporation shareholders’ equity and short-term and long-term debt are as follows:
|
|
|
|
|
|
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
|
|
|
Toyota Motor Corporation Shareholders’ equity |
|
|
35,924,826 |
|
|
|
39,918,854 |
|
Short-term and long-term debt |
|
|
38,792,879 |
|
|
|
43,205,469 |
| As of March 31, 2024, 2025 and 2026, the total number of authorized shares of TMC’s common stock was 50,000,000,000. Changes in the shares of common stock issued are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
For the years ended March 31, |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at beginning of year |
|
|
16,314,987,460 |
|
|
|
16,314,987,460 |
|
|
|
15,794,987,460 |
|
|
|
|
— |
|
|
|
(520,000,000 |
) |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16,314,987,460 |
|
|
|
15,794,987,460 |
|
|
|
15,794,987,460 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| The common stock issued by TMC is no-par value stock with no restrictions on shareholder rights, and is fully paid. The total number of treasury stock (including the common stock issued by TMC held by the stock grant ESOP) was 2,840,815,433, 2,746,057,686 and 2,761,602,986 as of March 31, 2024, 2025 and 2026, respectively. (3) Capital surplus and retained earnings Capital surplus consists of capital reserves and other capital surplus. Retained earnings consist of a retained earnings reserve and other retained earnings. The Companies Act of Japan provides that an amount equal to 10% of distributions from surplus paid by TMC and its Japanese subsidiaries be appropriated to a capital reserve or a retained earnings reserve. No further appropriations are required when the total amount of the capital reserves and the retained earnings reserve reaches 25% of capital stock. The Companies Act provides that the retained earnings reserve of TMC and its Japanese subsidiaries is restricted and cannot be used for dividend payments, and is excluded from the calculation of profits available for dividends. The amounts of statutory retained earnings of TMC available for dividend payments to shareholders were ¥ 18,333,862 million and ¥ 20,449,105 million as of March 31, 2025 and 2026, respectively. In accordance with customary practice in Japan, the distributions from surplus are not accrued in the financial statements for the corresponding period, but are recorded in the subsequent accounting period after shareholders’ approval has been obtained. Retained earnings at March 31, 2026 includes ¥ 3,898,125 million relating to equity in undistributed earnings of associates and joint ventures. The repurchase, reissuance and retirement of treasury stock are as follows: For the year ended March 31, 2024 Repurchase of treasury stock 1) Repurchasing of treasury stock resolved at the Board of Directors meeting held on May 10, 2023 Reason for repurchasing treasury stock - The repurchase was made to promote capital efficiency through more flexible measures than before while comprehensively considering factors such as the price level of its common stock. Details of matters relating to repurchase -
|
|
|
Number of common shares repurchased |
|
64,590,700 shares |
Total purchase price for repurchase of shares |
|
¥150,000 million | 2) Repurchasing of treasury stock resolved at the Board of Directors meeting held on November 1, 2023 Reason for repurchasing treasury stock - The repurchase was made to promote capital efficiency through more flexible measures than before while comprehensively considering factors such as the price level of its common stock. Details of matters relating to repurchase -
|
|
|
Number of common shares repurchased |
|
26,880,600 shares |
Total purchase price for repurchase of shares |
|
¥81,037 million | For the year ended March 31, 2025 Repurchase of treasury stock 1) Repurchasing of treasury stock resolved at the Board of Directors meeting held on November 1, 2023 Reason for repurchasing treasury stock - The repurchase was made to promote capital efficiency through more flexible measures than before while comprehensively considering factors such as the price level of its common stock. Details of matters relating to repurchase -
|
|
|
Number of common shares repurchased |
|
5,216,600 shares |
Total purchase price for repurchase of shares |
|
¥18,962 million | 2) Repurchasing of treasury stock resolved at the Board of Directors meeting held on May 8, 2024 and September 24, 2024 Reason for repurchasing treasury stock - The repurchase was made to promote capital efficiency through more flexible measures than before while comprehensively considering factors such as the price level of its common stock. Details of matters relating to repurchase -
|
|
|
Number of common shares repurchased |
|
420,633,175 shares |
Total purchase price for repurchase of shares |
|
¥1,160,051 million | Retirement of treasury stock Retiring of treasury stock resolved at the Board of Directors meeting held on May 8, 2024 Reason for retiring treasury stock - The retirement was made to relieve concerns regarding the dilution of TMC’s share value due to disposition of treasury stock in the future. Details of matters relating to retirement -
|
|
|
|
|
Number of common shares retired |
|
|
520,000,000 shares |
| For the year ended March 31, 2026 Repurchase of treasury stock Repurchasing of treasury stock resolved at the Board of Directors meeting held on May 8, 2024 and September 24, 2024 Reason for repurchasing treasury stock - The repurchase was made to promote capital efficiency through more flexible measures than before while comprehensively considering factors such as the price level of its common stock. Details of matters relating to repurchase -
|
|
|
Number of common shares repurchased |
|
16,226,100 shares |
Total purchase price for repurchase of shares |
|
¥39,949 million | (5) Other components of equity Other components of equity are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
| |
|
Net changes in
revaluation of
financial assets
measured at fair
value through other
comprehensive
income |
|
|
Remeasurements of
defined benefit
plans |
|
|
Exchange
differences on
translating foreign
operations |
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
933,702 |
|
|
|
— |
|
|
|
1,902,493 |
|
|
|
2,836,195 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income, net of tax |
|
|
716,048 |
|
|
|
56,434 |
|
|
|
1,344,621 |
|
|
|
2,117,103 |
|
Reclassification to retained earnings |
|
|
(341,709 |
) |
|
|
(45,625 |
) |
|
|
— |
|
|
|
(387,334 |
) |
Other comprehensive income for the period attributable to non-controlling interests |
|
|
(7,186 |
) |
|
|
(10,809 |
) |
|
|
(44,213 |
) |
|
|
(62,208 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at March 31, 2024 |
|
|
1,300,855 |
|
|
|
— |
|
|
|
3,202,901 |
|
|
|
4,503,756 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income, net of tax |
|
|
44,731 |
|
|
|
(85,084 |
) |
|
|
(705,678 |
) |
|
|
(746,031 |
) |
Reclassification to retained earnings |
|
|
(234,994 |
) |
|
|
94,635 |
|
|
|
— |
|
|
|
(140,359 |
) |
Other comprehensive income for the period attributable to non-controlling interests |
|
|
(1,153 |
) |
|
|
(9,551 |
) |
|
|
3,470 |
|
|
|
(7,233 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at March 31, 2025 |
|
|
1,109,439 |
|
|
|
— |
|
|
|
2,500,693 |
|
|
|
3,610,133 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income, net of tax |
|
|
334,394 |
|
|
|
91,099 |
|
|
|
1,104,451 |
|
|
|
1,529,944 |
|
Reclassification to retained earnings |
|
|
(180,113 |
) |
|
|
(79,403 |
) |
|
|
— |
|
|
|
(259,516 |
) |
Other comprehensive income for the period attributable to non-controlling interests |
|
|
(6,178 |
) |
|
|
(11,696 |
) |
|
|
(52,073 |
) |
|
|
(69,946 |
) |
Transfer to other comprehensive income associated with assets held for sale |
|
|
(148,535 |
) |
|
|
— |
|
|
|
(118,061 |
) |
|
|
(266,596 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at March 31, 2026 |
|
|
1,109,007 |
|
|
|
— |
|
|
|
3,435,012 |
|
|
|
4,544,019 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (6) Other comprehensive income The breakdown of other comprehensive income and the corresponding tax benefits (including non-controlling interests) are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
| |
|
For the year ended
March 31, 2024 |
|
| |
|
|
|
|
|
|
|
|
|
Items that will not be reclassified to profit (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
Net changes in revaluation of financial assets measured at fair value through other comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
Amount incurred during the year |
|
|
806,365 |
|
|
|
(248,826 |
) |
|
|
557,539 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
806,365 |
|
|
|
(248,826 |
) |
|
|
557,539 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Remeasurements of defined benefit plans |
|
|
|
|
|
|
|
|
|
|
|
|
Amount incurred during the year |
|
|
57,616 |
|
|
|
(11,289 |
) |
|
|
46,328 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
57,616 |
|
|
|
(11,289 |
) |
|
|
46,328 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares of other comprehensive income of equity method investees |
|
|
|
|
|
|
|
|
|
|
|
|
Amount incurred during the year |
|
|
156,118 |
|
|
|
— |
|
|
|
156,118 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
156,118 |
|
|
|
— |
|
|
|
156,118 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Items that may be reclassified subsequently to profit (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
Exchange differences on translating foreign operations |
|
|
|
|
|
|
|
|
|
|
|
|
Amount incurred during the year |
|
|
1,178,875 |
|
|
|
— |
|
|
|
1,178,875 |
|
Reclassification to profit (loss) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,178,875 |
|
|
|
— |
|
|
|
1,178,875 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net changes in revaluation of financial assets measured at fair value through other comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
Amount incurred during the year |
|
|
33,256 |
|
|
|
(10,459 |
) |
|
|
22,797 |
|
Reclassification to profit (loss) |
|
|
(15,267 |
) |
|
|
4,717 |
|
|
|
(10,550 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
17,989 |
|
|
|
(5,742 |
) |
|
|
12,247 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares of other comprehensive income of equity method investees |
|
|
|
|
|
|
|
|
|
|
|
|
Amount incurred during the year |
|
|
182,576 |
|
|
|
— |
|
|
|
182,576 |
|
Reclassification to profit (loss) |
|
|
(16,579 |
) |
|
|
— |
|
|
|
(16,579 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
165,996 |
|
|
|
— |
|
|
|
165,996 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total other comprehensive income |
|
|
2,382,959 |
|
|
|
(265,856 |
) |
|
|
2,117,103 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the year ended
March 31, 2025 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Items that will not be reclassified to profit (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
Net changes in revaluation of financial assets measured at fair value through other comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
Amount incurred during the year |
|
|
153,164 |
|
|
|
(51,035 |
) |
|
|
102,129 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
153,164 |
|
|
|
(51,035 |
) |
|
|
102,129 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Remeasurements of defined benefit plans |
|
|
|
|
|
|
|
|
|
|
|
|
Amount incurred during the year |
|
|
(154,517 |
) |
|
|
44,919 |
|
|
|
(109,598 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
(154,517 |
) |
|
|
44,919 |
|
|
|
(109,598 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares of other comprehensive income of equity method investees |
|
|
|
|
|
|
|
|
|
|
|
|
Amount incurred during the year |
|
|
(63,213 |
) |
|
|
— |
|
|
|
(63,213 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
(63,213 |
) |
|
|
— |
|
|
|
(63,213 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Items that may be reclassified subsequently to profit (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
Exchange differences on translating foreign operations |
|
|
|
|
|
|
|
|
|
|
|
|
Amount incurred during the year |
|
|
(40,479 |
) |
|
|
— |
|
|
|
(40,479 |
) |
Reclassification to profit (loss) |
|
|
(787,369 |
) |
|
|
— |
|
|
|
(787,369 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
(827,848 |
) |
|
|
— |
|
|
|
(827,848 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net changes in revaluation of financial assets measured at fair value through other comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
Amount incurred during the year |
|
|
40,503 |
|
|
|
(9,485 |
) |
|
|
31,018 |
|
Reclassification to profit (loss) |
|
|
189 |
|
|
|
(49 |
) |
|
|
140 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
40,693 |
|
|
|
(9,534 |
) |
|
|
31,158 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares of other comprehensive income of equity method investees |
|
|
|
|
|
|
|
|
|
|
|
|
Amount incurred during the year |
|
|
127,022 |
|
|
|
— |
|
|
|
127,022 |
|
Reclassification to profit (loss) |
|
|
(5,682 |
) |
|
|
— |
|
|
|
(5,682 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
121,340 |
|
|
|
— |
|
|
|
121,340 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total other comprehensive income |
|
|
(730,381 |
) |
|
|
(15,650 |
) |
|
|
(746,031 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
The gain on the disposal of certain consolidated subsidiaries was reclassified from “Exchange differences on translating foreign operations” to “Foreign exchange gain (loss), net” in the consolidated statement of income for fiscal 2025.
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
| |
|
For the year ended
March 31, 2026 |
|
| |
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
| Items that will not be reclassified to profit (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
| Net changes in revaluation of financial assets measured at fair value through other comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
| Amount incurred during the year |
|
|
513,231 |
|
|
|
(161,547 |
) |
|
|
351,684 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net changes |
|
|
513,231 |
|
|
|
(161,547 |
) |
|
|
351,684 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Remeasurements of defined benefit plans |
|
|
|
|
|
|
|
|
|
|
|
|
| Amount incurred during the year |
|
|
127,129 |
|
|
|
(25,777 |
) |
|
|
101,352 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net changes |
|
|
127,129 |
|
|
|
(25,777 |
) |
|
|
101,352 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares of other comprehensive income of equity method investees |
|
|
|
|
|
|
|
|
|
|
|
|
| Amount incurred during the year |
|
|
22,331 |
|
|
|
— |
|
|
|
22,331 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net changes |
|
|
22,331 |
|
|
|
— |
|
|
|
22,331 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Items that may be reclassified subsequently to profit (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
| Exchange differences on translating foreign operations |
|
|
|
|
|
|
|
|
|
|
|
|
| Amount incurred during the year |
|
|
946,309 |
|
|
|
— |
|
|
|
946,309 |
|
| Reclassification to profit (loss) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net changes |
|
|
946,309 |
|
|
|
— |
|
|
|
946,309 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net changes in revaluation of financial assets measured at fair value through other comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
| Amount incurred during the year |
|
|
(78,919 |
) |
|
|
25,603 |
|
|
|
(53,316 |
) |
| Reclassification to profit (loss) |
|
|
185 |
|
|
|
(51 |
) |
|
|
135 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net changes |
|
|
(78,733 |
) |
|
|
25,552 |
|
|
|
(53,181 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares of other comprehensive income of equity method investees |
|
|
|
|
|
|
|
|
|
|
|
|
| Amount incurred during the year |
|
|
173,617 |
|
|
|
— |
|
|
|
173,617 |
|
| Reclassification to profit (loss) |
|
|
(12,167 |
) |
|
|
— |
|
|
|
(12,167 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net changes |
|
|
161,450 |
|
|
|
— |
|
|
|
161,450 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total other comprehensive income |
|
|
1,691,717 |
|
|
|
(161,773 |
) |
|
|
1,529,944 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Paid dividend amounts are as follows: For the year ended March 31, 2024
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total amount
of dividends
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
The Board of Directors Meeting on May 10, 2023 |
|
|
Common shares |
|
|
|
474,781 |
|
|
|
35.00 |
|
|
March 31, 2023 |
|
May 26, 2023 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Board of Directors Meeting on November 1, 2023 |
|
|
Common shares |
|
|
|
405,416 |
|
|
|
30.00 |
|
|
September 30, 2023 |
|
November 22, 2023 | For the year ended March 31, 2025
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total amount
of dividends
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
The Board of Directors Meeting on May 8, 2024 |
|
|
Common shares |
|
|
|
606,338 |
|
|
|
45.00 |
|
|
March 31, 2024 |
|
May 24, 2024 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Board of Directors Meeting on November 6, 2024 |
|
|
Common shares |
|
|
|
525,991 |
|
|
|
40.00 |
|
|
September 30, 2024 |
|
November 26, 2024 | For the year ended March 31, 2026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total amount
of dividends
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
The Board of Directors Meeting on May 8, 2025 |
|
|
Common shares |
|
|
|
652,446 |
|
|
|
50.00 |
|
|
March 31, 2025 |
|
May 26, 2025 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Board of Directors Meeting on November 5, 2025 |
|
|
Common shares |
|
|
|
586,527 |
|
|
|
45.00 |
|
|
September 30, 2025 |
|
November 26, 2025 | Dividends with a record date within the year ended March 31, but with an effective date after the end of that year are as follows: For the year ended March 31, 2026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
Total amount
of dividends
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| The Board of Directors Meeting on May 8, 2026 |
|
|
Common shares |
|
|
|
651,697 |
|
|
|
50.00 |
|
|
March 31, 2026 |
|
May 26, 2026 |
|